Systemic administration of radionuclides in neuroblastoma as planned radiotherapeutic intervention.
Lashford
L S
LS
Imperial Cancer Research Fund Laboratory, Institute of Child Health, London, England.
Clarke
J
J
Kemshead
J T
JT
D019797:3-Iodobenzylguanidine; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D002143:Callitrichinae; D002648:Child; D003287:Contrast Media; D004337:Drug Carriers; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D007462:Iodobenzenes / Q000008:administration & dosage; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009447:Neuroblastoma / Q000532:radiotherapy*; D014018:Tissue Distribution
D000911:Antibodies, Monoclonal; D003287:Contrast Media; D004337:Drug Carriers; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine